Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060230
Filing Date
2013-11-12
Accepted
2013-11-12 08:11:00
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v359330_10q.htm 10-Q 1042533
2 EXHIBIT 31.1 v359330_ex31-1.htm EX-31.1 13303
3 EXHIBIT 31.2 v359330_ex31-2.htm EX-31.2 13465
4 EXHIBIT 32.1 v359330_ex32-1.htm EX-32.1 7165
5 EXHIBIT 32.2 v359330_ex32-2.htm EX-32.2 7819
  Complete submission text file 0001144204-13-060230.txt   4856089

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT erb-20130930.xml EX-101.INS 568195
7 XBRL TAXONOMY EXTENSION SCHEMA erb-20130930.xsd EX-101.SCH 52454
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE erb-20130930_cal.xml EX-101.CAL 40642
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE erb-20130930_def.xml EX-101.DEF 284485
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE erb-20130930_lab.xml EX-101.LAB 265547
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE erb-20130930_pre.xml EX-101.PRE 318869
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127 305-324-2300
ERBA Diagnostics, Inc. (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14798 | Film No.: 131207077
SIC: 2834 Pharmaceutical Preparations